S.M. Pharmaceuticals Private Limited, a under cirp private limited company, was established on 19 December 2018 in Bangalore North, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230KA2018PTC119625. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹5.50 Cr.
Employing 5 professional, Its leadership includes Yashwanth Kanchu Raju (Director), Kanchu Doraswamy Raju (Director), Mallikarjuna Setty Nethi (Irp/Rp/Liquidator). Past directors included Kootgal Varadaiah Rashmi, Subramanyam Sharma, Yashwanth Kanchu Raju. It holds ₹21.02 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 44/8 Ground Floor, 15Th Cross Malleshwaram, Bangalore North, Karnataka, 560003.
U24230KA2018PTC119625
119625
19 December 2018
₹10.00 Cr
₹5.50 Cr
Roc Bangalore
Unlisted
Under Cirp
Explore comprehensive insights into S.M. Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yashwanth Kanchu Raju | Director | 20 Dec 2023 | Current |
| Kanchu Doraswamy Raju | Director | 20 Dec 2023 | Current |
| Mallikarjuna Setty Nethi | Irp/Rp/Liquidator | 07 Jul 2025 | Current |
| Vedavathi | Director | 29 May 2025 | Current |
| Suchithra Raja | Director | 29 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Jan 2024 | Past |
| Pramod Abcsdd | Additional Director | 01 Jan 2024 | Past |
| Pramod Abcsdd | Director | 05 Oct 2023 | Past |
| Pramod Abcsdd | Director | 05 Oct 2023 | Past |
| Pramod Abcsdd | Additional Director | 18 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 18 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
S.M. Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 12.31% decrease. The company also saw a substantial fall in profitability, with a 33.16% decrease in profit. The company's net worth moved up by a moderate rise of 2.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, S.M. Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹210,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2019 | State Bank Of India | ₹21.02 Cr | Open |
Explore comprehensive loan charge details -
S.M. Pharmaceuticals has a workforce of 5 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of S.M. Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.M. Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mallikarjuna Setty Nethi was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 07 Jul 2025 & has been associated with this company since 4 months 26 days . was documented.
The activity Vedavathi was appointed as a Director was appointed as a Director on 29 May 2025 & has been associated with this company since 6 months 4 days . was completed.
Progress on Suchithra Raja was appointed as a Director was appointed as a Director on 29 May 2025 & has been associated with this company since 6 months 4 days . was documented.
S.M. Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on S.M. Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity Yashwanth Kanchu Raju was appointed as a Director was appointed as a Director on 20 Dec 2023 & has been associated with this company since 1 year 11 months . was completed.
The CIN of S.M. Pharmaceuticals Private Limited is U24230KA2018PTC119625.
S.M. Pharmaceuticals Private Limited is headquartered at 44/8 Ground Floor, 15Th Cross Malleshwaram, Bangalore North, Karnataka, 560003.
S.M. Pharmaceuticals Private Limited was incorporated on 19 December 2018.
The current directors of S.M. Pharmaceuticals Private Limited are
The primary industry of S.M. Pharmaceuticals Private Limited is Manufacturing.
S.M. Pharmaceuticals Private Limited is unlisted.
The authorized capital of S.M. Pharmaceuticals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹5.50 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX